Zhitong Finance App News, Aimeike (300896.SZ) announced that Beijing Norbot Biotechnology Co., Ltd. (“Norbot Biotech”), a wholly-owned subsidiary of the company, recently received approval from the State Drug Administration to issue a “Drug Clinical Trial Approval Notice” for simeglutide injections and will conduct clinical trials in the near future.

Zhitongcaijing · 10/14 12:41
Zhitong Finance App News, Aimeike (300896.SZ) announced that Beijing Norbot Biotechnology Co., Ltd. (“Norbot Biotech”), a wholly-owned subsidiary of the company, recently received approval from the State Drug Administration to issue a “Drug Clinical Trial Approval Notice” for simeglutide injections and will conduct clinical trials in the near future.